Distinguished Speakers

                             

Winfried	Barchet	University of Bonn	Germany
Stefan	Bauer	University of Marburg	Germany
Arndt	Borkhardt	Universitätsklinik Düsseldorf	Germany
Tom	Brown	University of Southampton	UK
David	Bumcrot	Alnylam Pharmaceuticals Inc.	USA
Marvin	Caruthers	University of Colorado	USA
Robert L.	Coffman	Dynavax Technologies	USA
Rosanne	Crooke	Isis Pharmaceuticals Inc.	USA
Stefan	Endres	LMU Munich	Germany
Michael	Famulok	Rheinische Friedrich-Wilhelms-Universität	Germany
Takashi	Fujita	Kyoto University	Japan
Mike	Gait	MRC Laboratory of Molecular Biology	England
Volker	Gekeler	Nycomed GmbH	Germany
Klaus	Giese	Silence Therapeutics AG	Germany
Martin	Gleave	OncoGenex Technologies Inc.	Canada
Gunther	Hartmann	Universitätsklinikum Bonn	Germany
Jeremy	Heidel	Calando Pharmaceuticals Inc.	USA
Piet	Herdewijn	Katholieke Universiteit Leuven	Belgium
Veit	Hornung	University of Massachusetts Medical School	USA
Craig P.	Hunter	Harvard University	USA
Mark A.	Kay	Stanford University	USA
Anthony	Keefe	Archemix Corp.	USA
Makoto	Koizumi	Sankyo Co. Ltd.	Japan
Thomas	Kramps	CureVac GmbH	Germany
Anna M.	Krichevsky	Harvard Medical School	USA
Arthur	Krieg	Coley Pharmaceutical Group Inc.	USA
Jens	Kurreck	Free University Berlin	Germany
Michael	Lahn	Eli Lilly and Company	USA
Song	Li	University of Pittsburgh	USA
Peter	Linsley	Rosetta Inpharmatics	USA
Michael	Lotze	University of Pittsburgh	USA
Patrick	Lu	Sirnaomics, Inc.	USA
Gunter	Meister	MPI of Biochemistry	Germany
Ronald	Micura	Universität Innsbruck	Austria
Brett	Monia	Isis Pharmaceuticals Inc.	USA
Francois	Natt	Novartis Institutes for Biomedical Research	Switzerland
Henrik	Ørum	Santaris Pharma A/S	Denmark
Virendra	Pandey	University of Medicine and Dentistry of New Jersey	USA
Steffen	Panzner	Novosom AG	Germany
Dinshaw	Patel	Memorial Sloan Kettering Cancer Center	USA
Volker	Patzel	Max Planck Institute for Infection Biology	Germany
Lukas	Pelkmans	ETH Zürich	Switzerland
Barry A.	Polisky	Sirna Therapeutics	USA
Nikolaus	Rajewsky	Max Delbrück Center for Molecular Medicine	Germany
Paolo	Renzi	Topigen Pharmaceuticals Inc.	Canada
Ingo	Roehl	Roche Kulmbach GmbH	Germany
John J.	Rossi	Beckmann Research Institute of the City of Hope	USA
Alan B.	Sachs	Merck Research Laboratories	USA
Dinah	Sah	Alnylam Pharmaceuticals Inc.	USA
Karl-H.	Schlingensiepen	Antisense Pharma GmbH	Germany
Jost	Seibler	ARTEMIS Pharmaceuticals GmbH	Germany
Hermona	Soreq	The Hebrew University of Jerusalem	Israel
Markus	Stoffel	ETH Zürich	Switzerland
Thomas	Tuschl	Rockefeller University	USA
Thomas	Tüting	Universitätsklinikum Bonn	Germany
Joseph	Vyle	Queen's University Belfast	UK
Hermann	Wagner	TU München	Germany

Print this PAGE